The present study demonstrates, for the first time, that the TRM cell is a novel player triggering the adaptive immune activation in T1D, which also expands the understanding of CD8+ T recruitment other than triggering by autoantigens released from β cells. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.